Enas Al-Banna
Friday, February 24, 2023 08:00 PM
The results, published in the Journal of the Royal Society of Medicine, confirmed that 59% of patients with Corona disease Long-term patients have multi-organ weakness, with symptoms and reduced function lasting between six and 12 months.
Senior author Professor Amitava Banerjee, at the Institute of Health Informatics at University College London, said, according to “timesnownews”: “Symptoms were common in the sixth and twelfth month and are associated with female gender, younger age, and a single organ disorder, while long symptoms persisted in 59% of Corona patients.” A year after initial symptoms, even those who weren’t severely affected when they were first diagnosed with the virus.
The study reported a reduction in symptoms between six and 12 months – severe dyspnea (in 38% to 30% of patients), cognitive impairment (48% to 38%) and health-related poor quality of life (57% to 45%).
Many studies confirm the persistence of symptoms in individuals with corona for a long period of up to one year, and according to the report now, three out of five people with long corona disease suffer from weakness in at least one organ, and one in four suffers from weakness in two or more organs. In some cases, without symptoms.
The team included 536 long-term COVID-19 patients in the study, of whom 331 (62%) were diagnosed with organ impairment six months after the initial diagnosis.
The researchers said the underlying mechanisms of the long coronavirus remain elusive, and they found no evidence through symptoms, blood investigations, or MRI scans to clearly identify subtypes of the long coronavirus, and noted that future research should take into account associations between symptoms and multiorgan weakness. and function in larger groups.
And they continued, “The weakening of organs in long-term Corona disease has implications for symptoms, quality of life, and long-term health, which indicates the need for prevention and integrated care for long-term Covid patients.”
